Business · 14/10/2014
FDA Releases Draft Guidance for Flow Cytometric Devices
The FDA has made available a draft guidance document addressing concerns related to submissions for flow cytometric devices used in in vitro diagnostic tests for blood cell analysis, and invites feedback from industry and FDA staff.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →